NCT00482235View on ClinicalTrials.gov

A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

MK0359

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00482235 - A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016) | Biotech Hunter | Biotech Hunter